Delivery Order SPE2DX22D0049-SPE2D824FA2EF

Award Date 6/24/24
Potential Completion Date 6/25/24
Potential Value $71K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $15,041.10, was issued by the Medical Supply Chain division of the U.S. Defense Department's Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical products and...
This federal contract award, valued at $35,638.65, was issued by the Medical Supply Chain division of the Department of Defense's Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical products and...
This federal contract award, valued at $166,891.44, was issued by the Medical Supply Chain division of the Department of Defense's Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999.00 through December 2025. Under this contract, Amerisourcebergen will provide a range of pharmaceutical products and medical...
This federal contract award, valued at $85,574.42, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical...
This federal contract award, valued at $71,548.51, was issued by the Medical Supply Chain division of the U.S. Department of Defense's Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of...
This federal contract award, valued at $157,900.16, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999.00 through December 2025. Under this specific award, Amerisourcebergen will provide a variety of pharmaceutical products and medical supplies,...
This federal contract award, valued at $131,341.45, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a delivery order under an Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to...
This federal contract award, valued at $1,974.84, was issued by the Medical Supply Chain division of the U.S. Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to supply a wide range of pharmaceutical products and medical supplies,...
This federal contract award, valued at $17,856.06, was issued by the Medical Supply Chain division of the U.S. Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a...
This federal contract award, valued at $29,348.74, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, which has a ceiling value of up to $999,999,999.00 and runs through December 31, 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical products and...
  • SPE2DX22D0049
    Indefinite Delivery Contract
  • SPE2DX22D0049-SPE2D824FA2EF
    Delivery Order

This federal contract award, valued at $71,470.15, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This contract does not have a set-aside designation. Under this agreement, Amerisourcebergen will deliver specialty, brand name, generic, and over-the-counter medications, as well as critical care materials such as syringes, vials, and test kits, to support military treatment programs and facilities globally.

Generated 9/23/24, 10:14 AM